| Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain S Feng, Y Yang, Y Mei, L Ma, D Zhu, N Hoti, M Castanares, M Wu Cellular signalling 19 (10), 2056-2067, 2007 | 519 | 2007 |
| Comprehensive analysis of protein glycosylation by solid-phase extraction of N-linked glycans and glycosite-containing peptides. ZH Sun S, Shah P, Eshghi ST, Yang W, Trikannad N, Yang S, Chen L, Aiyetan P ... Nat Biotechnol, 2015 | 214* | 2015 |
| Downregulation of homologous recombination DNA repair genes by HDAC inhibition in prostate cancer is mediated through the E2F1 transcription factor SK Kachhap, N Rosmus, SJ Collis, MSQ Kortenhorst, MD Wissing, ... PloS one 5 (6), e11208, 2010 | 187 | 2010 |
| Chronic Administration of Valproic Acid Inhibits Prostate Cancer Cell Growth In vitro and In vivo Q Xia, J Sung, W Chowdhury, C Chen, N Höti, S Shabbeer, M Carducci, ... Cancer Research 66 (14), 7237-7244, 2006 | 157 | 2006 |
| Integrated proteomic and glycoproteomic analyses of prostate cancer cells reveal glycoprotein alteration in protein abundance and glycosylation P Shah, X Wang, W Yang, ST Eshghi, S Sun, N Hoti, L Chen, S Yang, ... Molecular & Cellular Proteomics 14 (10), 2753-2763, 2015 | 112 | 2015 |
| Prevalence of HBV and HBV vaccination coverage in health care workers of tertiary hospitals of Peshawar, Pakistan S Attaullah, S Khan, Naseemullah, S Ayaz, SN Khan, I Ali, N Hoti, S Siraj Virology journal 8, 1-5, 2011 | 111 | 2011 |
| Site-specific fucosylation analysis identifying glycoproteins associated with aggressive prostate cancer cell lines using tandem affinity enrichments of intact glycopeptides … J Zhou, W Yang, Y Hu, N Hoti, Y Liu, P Shah, S Sun, D Clark, S Thomas, ... Analytical chemistry 89 (14), 7623-7630, 2017 | 74 | 2017 |
| A single amino acid change (Asp 53→ Ala53) converts Survivin from anti-apoptotic to pro-apoptotic Z Song, S Liu, H He, N Hoti, Y Wang, S Feng, M Wu Molecular biology of the cell 15 (3), 1287-1296, 2004 | 71 | 2004 |
| Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy N Höti, W Chowdhury, JT Hsieh, MD Sachs, SE Lupold, R Rodriguez Molecular Therapy 14 (6), 768-778, 2006 | 65 | 2006 |
| Valproic Acid Inhibits the Growth of Cervical Cancer both In Vitro and In Vivo S Sami, N Höti, HM Xu, Z Shen, X Huang Journal of biochemistry 144 (3), 357-362, 2008 | 61 | 2008 |
| Triphenyl Tin Benzimidazolethiol, a Novel Antitumor Agent, Induces Mitochondrial-Mediated Apoptosis in Human Cervical Cancer Cells via Suppression of HPV-18 … N Höti, J Ma, S Tabassum, Y Wang, M Wu Journal of biochemistry 134 (4), 521-528, 2003 | 55 | 2003 |
| p53-dependent apoptotic mechanism of a new designer bimetallic compound tri-phenyl tin benzimidazolethiol copper chloride (TPT-CuCl2): in vivo studies in Wistar rats as well as … N Höti, D Zhu, Z Song, Z Wu, S Tabassum, M Wu Journal of Pharmacology and Experimental Therapeutics 311 (1), 22-33, 2004 | 49 | 2004 |
| Simultaneous analyses of N-linked and O-linked glycans of ovarian cancer cells using solid-phase chemoenzymatic method S Yang, N Höti, W Yang, Y Liu, L Chen, S Li, H Zhang Clinical proteomics 14, 1-11, 2017 | 47 | 2017 |
| Detection of aggressive prostate cancer associated glycoproteins in urine using glycoproteomics and mass spectrometry X Jia, J Chen, S Sun, W Yang, S Yang, P Shah, N Hoti, B Veltri, H Zhang Proteomics 16 (23), 2989-2996, 2016 | 40 | 2016 |
| Overexpression of α (1, 6) fucosyltransferase in the development of castration-resistant prostate cancer cells N Höti, S Yang, Y Hu, P Shah, MC Haffner, H Zhang Prostate cancer and prostatic diseases 21 (1), 137-146, 2018 | 38 | 2018 |
| The antiangiogenic and therapeutic implications of endostatin. B Ren, N Höti, X Rabasseda, YZ Wang, M Wu Methods and findings in experimental and clinical pharmacology 25 (3), 215-224, 2003 | 36 | 2003 |
| A comprehensive analysis of FUT8 overexpressing prostate cancer cells reveals the role of EGFR in castration resistance N Höti, TS Lih, J Pan, Y Zhou, G Yang, A Deng, L Chen, M Dong, ... Cancers 12 (2), 468, 2020 | 35 | 2020 |
| Impact of increased FUT8 expression on the extracellular vesicle proteome in prostate cancer cells DJ Clark, M Schnaubelt, N Hoti, Y Hu, Y Zhou, M Gooya, H Zhang Journal of proteome research 19 (6), 2195-2205, 2020 | 33 | 2020 |
| Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets Y Zhou, TM Lih, J Pan, N Höti, M Dong, L Cao, Y Hu, KC Cho, SY Chen, ... Journal of Hematology & Oncology 13, 1-15, 2020 | 29 | 2020 |
| Androgen receptor attenuation of Ad5 replication: implications for the development of conditionally replication competent adenoviruses N Höti, Y Li, CL Chen, WH Chowdhury, DC Johns, Q Xia, A Kabul, ... Molecular Therapy 15 (8), 1495-1503, 2007 | 29 | 2007 |
Hui ZhangProfessor of Pathology, Oncology, Chemical and Biomolecular Engineering, and Urology, Johns HopkinsAdresă de e-mail confirmată pe jhmi.edu
